Peter Sordillo
Hoofd Techniek/Wetenschap/O&O bij SignPath Pharma, Inc.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Kai P. Larson | M | 60 |
SignPath Pharma, Inc.
 SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | 9 jaar |
| Jack Levine | M | 73 |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | 14 jaar |
| Arthur P. Bollon | M | 81 |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | 16 jaar |
| Kristján Tómas Ragnarsson | M | 80 |
Icahn School of Medicine at Mount Sinai
| - |
| Tom Strauss | M | 82 |
Icahn School of Medicine at Mount Sinai
| - |
| George M. Diaz | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| John R. Tomasula | M | 69 |
Icahn School of Medicine at Mount Sinai
| 22 jaar |
| Ross L. Cagan | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Barbara Paris | M | 72 |
Icahn School of Medicine at Mount Sinai
| 21 jaar |
| Hina Waheed Chaudhry | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Scott L. Friedman | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Robert J. Desnick | M | - |
Icahn School of Medicine at Mount Sinai
| 15 jaar |
| Kevin David Costa | M | - |
Icahn School of Medicine at Mount Sinai
| 15 jaar |
| Jeffrey Vacirca | M | 55 |
Icahn School of Medicine at Mount Sinai
| 6 jaar |
| Gary Goldenberg | M | 47 |
Icahn School of Medicine at Mount Sinai
| 15 jaar |
| Sundar Jagannath | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Joshua Brody | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Stephen Dahmer | M | 49 |
Icahn School of Medicine at Mount Sinai
| 9 jaar |
| Stephen Spencer | M | - |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | 7 jaar |
| Eric Schadt | M | 59 |
Icahn School of Medicine at Mount Sinai
| 13 jaar |
| Gregory M. Heard | M | - |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | 5 jaar |
| Edward Lung | M | - |
Icahn School of Medicine at Mount Sinai
| 21 jaar |
| Jeffrey S. Starman | M | - |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | 3 jaar |
| Bradley J. Hayosh | M | - |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | 3 jaar |
| Lisa Edelmann | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Lawrence Tanenbaum | M | 66 |
Icahn School of Medicine at Mount Sinai
| 16 jaar |
| Judy Cho | F | - |
Icahn School of Medicine at Mount Sinai
| - |
| Elissa Levin | F | - |
Icahn School of Medicine at Mount Sinai
| - |
| Alain Carpentier | M | 91 |
Icahn School of Medicine at Mount Sinai
| - |
| Andrew Russell | M | 52 |
Icahn School of Medicine at Mount Sinai
| 9 jaar |
| Michael R. Hausman | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| John H. Morrison | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Steven J. Burakoff | M | 81 |
Icahn School of Medicine at Mount Sinai
| - |
| Melvin M. van Woert | M | 93 |
Icahn School of Medicine at Mount Sinai
| 46 jaar |
| Samuel Marcus Waxman | M | - |
Icahn School of Medicine at Mount Sinai
| 41 jaar |
| Lester B. Salans | M | 88 |
Icahn School of Medicine at Mount Sinai
| - |
| Ariel Recanati | M | 60 |
Icahn School of Medicine at Mount Sinai
| - |
| Daniel Moros | M | - |
Icahn School of Medicine at Mount Sinai
| 33 jaar |
| Michael Donovan | M | 70 |
Icahn School of Medicine at Mount Sinai
| 13 jaar |
| Stephen B. Thacker | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Holly G. Atkinson | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Francesco Ramirez | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Carlos Cordón-Cardó | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Dennis Charney | M | 72 |
Icahn School of Medicine at Mount Sinai
| 20 jaar |
| Steve Hochberg | M | 62 |
Icahn School of Medicine at Mount Sinai
| - |
| Janice L. Gabrilove | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Arthur A. Klein | M | 76 |
Icahn School of Medicine at Mount Sinai
| - |
| E. Premkumar Reddy | M | 80 |
Icahn School of Medicine at Mount Sinai
| 14 jaar |
| Hendrick Coenraad Hemker | M | 90 |
Icahn School of Medicine at Mount Sinai
| - |
| Robert Seguso | M | - |
SignPath Pharma, Inc.
SignPath Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SignPath Pharma, Inc. operates as a development stage biotechnology company. It engages in the research and development of curcumin formulations for the treatment of cancer, neurologic disorders and mitigates drug-induced cardiac arrhythmia. The company was founded by Bruce Meyers in May 15, 2006 and is headquartered in Sandy, UT. | 7 jaar |
| Angela Diaz | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Jay Schechtman | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Preeti Parikh | M | - |
Icahn School of Medicine at Mount Sinai
| - |
| Andrew M. Saul | M | 77 |
Icahn School of Medicine at Mount Sinai
| - |
| Lisa Satlin | F | - |
Icahn School of Medicine at Mount Sinai
| - |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 55 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Peter Sordillo
- Persoonlijk netwerk
